From: Upregulation of MIF as a defense mechanism and a biomarker of Alzheimer’s disease
Subjects
Sample size (female/male)
Age (mean ± SD)
Control
30 (14/16)
61.2 ± 9.6
AD
28 (14/14)
69.4 ± 6.8
MCI
10 (4/6)
68.9 ± 9.6
VD
17 (8/9)
66.3 ± 10.2